Quantificare

Quantificare is a global leader in standardized 2D/3D imaging for aesthetic medicine and clinical research. Its technology platform, centered on the LifeViz product line, enables objective, longitudinal assessment of skin and body changes, which is critical for aesthetic treatment documentation and proving efficacy in dermatology and aesthetic clinical trials. The company has evolved a dual business model: direct sales/leasing of imaging hardware to physicians and a full-service imaging CRO offering for pharmaceutical and biotech companies. With a recent legal victory protecting its IP and a new AI partnership, Quantificare is positioning itself at the intersection of digital imaging, data standardization, and AI-driven analysis.

Standardized and validated 2D/3D imaging systems (LifeViz product line) and software for reproducible image capture, longitudinal analysis, 3D volume measurement, and skin feature quantification. Recently augmented by an AI-powered dermatology imaging platform developed in partnership with Legit.Health.

Quantificare competes in the aesthetic imaging space with companies like Canfield Scientific (subject of its patent lawsuit), Cortex Technology, and others offering 2D/3D imaging systems. As an imaging CRO, it competes with larger, full-service CROs that have imaging divisions as well as specialized imaging service providers. Its focus on standardization, portable technology, and recent AI integration are key competitive differentiators.